Geron (GERN) Asset Utilization Ratio (2011 - 2026)
Geron (GERN) posted Asset Utilization Ratio of 0.03 for Q1 2026, up 330.43% sequentially from 0.01 in Q4 2025, and down 57.7% YoY from 0.07 in Q1 2025.
Geron (GERN) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Geron has reported Asset Utilization Ratio for 16 years, with the latest figure at 0.03 in Q1 2026.
- Quarterly Asset Utilization Ratio fell 57.7% year-over-year to 0.03 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.03 (down 57.7% YoY) and the FY2025 annual result came in at 0.01, up 554.44% from the prior year.
- Asset Utilization Ratio grew to 0.03 in Q1 2026 per GERN's latest filing, from 0.01 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.19 in Q3 2025 and troughed at 0.0 in Q1 2024.
- A 5-year average of 0.03 and a median of 0.01 in 2022 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio sank 88.25% in 2023, then surged 10556.35% in 2025.
- Over 5 years, Asset Utilization Ratio stood at 0.0 in 2022, then tumbled by 72.83% to 0.0 in 2023, then grew by 25.53% to 0.0 in 2024, then soared by 604.11% to 0.01 in 2025, then jumped by 330.43% to 0.03 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.03, 0.01, and 0.19 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.20 Bn | 131.35 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 86.09 Bn | 78.10 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.04 Bn | 53.90 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 42.04 Bn | 36.94 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.04 Bn | 9.65 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.50 Bn | 26.33 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.34 Bn | 26.50 Bn | - | 0.13 |
| 10 | Geron | 1.03 Mn | -299.82 Mn | - | 0.46 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.46 |
| Mar 31, 2026 | 0.03 |
| Dec 31, 2025 | 0.01 |
| Sep 30, 2025 | 0.19 |
| Jun 30, 2025 | 0.16 |
| Mar 31, 2025 | 0.07 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.07 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.00 |